Ashley Grossman MD, endokrinolog, neuroendokrinolog.
Grossman, Ashley
Grossman, Ashley B.
Grossman, A.
Grossman, Ashley, 1948-
VIAF ID: 76377292 (Personal)
Permalink: http://viaf.org/viaf/76377292
Preferred Forms
-
100 0 _ ‡a Ashley Grossman ‡c MD, endokrinolog, neuroendokrinolog.
-
200 _ | ‡a Grossman ‡b Ashley
-
100 1 _ ‡a Grossman, A.
-
100 1 _ ‡a Grossman, Ashley
-
-
100 1 _ ‡a Grossman, Ashley
-
-
100 1 _ ‡a Grossman, Ashley
-
-
100 1 _ ‡a Grossman, Ashley B
-
-
100 1 _ ‡a Grossman, Ashley B.
-
-
4xx's: Alternate Name Forms (9)
Works
Title | Sources |
---|---|
Advanced Practice in Endocrinology Nursing |
![]() |
Clinical endocrinology |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Clinical perspectives of endogenous opioids production, c1992: |
![]() ![]() |
The ectopic ACTH syndrome. |
![]() |
Frontiers in paediatric neuroendocrinology, 1994: |
![]() ![]() |
Handbuch der experimentellen Pharmakologie |
![]() |
Incydentaloma nadnerczy : "reguła czterech" |
![]() |
Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway |
![]() |
The management of Cushing's disease : from investigation to treatment |
![]() |
Multimodality palliative treatment of ¹¹¹In-pentetreotide negative/¹²³I-MIBG positive metastatic carcinoid : a case report |
![]() |
Oksfordzki podręcznik endokrynologii |
![]() ![]() |
Oxford desk reference |
![]() |
Pharmacotherapeutics of the thyroid gland, 1997: |
![]() ![]() ![]() ![]() |
Recurrent pituitary ependymoma: a complex clinical problem |
![]() |
Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab |
![]() |
The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndrome |
![]() |
The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas |
![]() |
Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing's syndrome. |
![]() |
Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism |
![]() |
The release of leptin and its effect on hormone release from human pituitary adenomas |
![]() |
Renin-Angiotensin System Blockade Improves Cardiac Indices in Acromegaly Patients. |
![]() |
Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines |
![]() |
The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning |
![]() |
The role of AMP-activated protein kinase in obesity |
![]() |
The role of carbon monoxide in the regulation of neuroendocrine function. |
![]() |
The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors |
![]() |
The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes |
![]() |
The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance |
![]() |
Role of regulatory factors in pituitary tumour formation |
![]() |
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. |
![]() |
SAT-462 AIP Mutation-Positive Patients with Somatotropinomas End up Taller and Requiring Radiotherapy More Often Compared to AIP Mutation-Negative Patients: Data from 784 Familial and Young-Onset Cases. |
![]() |
Screening children at risk of developing inherited endocrine neoplasia syndromes |
![]() |
Secondary forms of polycystic ovary syndrome. |
![]() |
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models. |
![]() |
Sequelae and survivorship in patients treated with |
![]() |
Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours |
![]() |
The Short Synacthen (Corticotropin) Test Can Be Used to Predict Recovery of Hypothalamo-Pituitary-Adrenal Axis Function |
![]() |
Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors |
![]() |
A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotide |
![]() |
Somatic and germline mutations in NETs: Implications for their diagnosis and management |
![]() |
Specific electrocardiographic features associated with Cushing's disease |
![]() |
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. |
![]() |
Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen |
![]() |
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures |
![]() |
TARGETED ALPHA PARTICLE THERAPY FOR NEUROENDOCRINE TUMOURS: THE NEXT GENERATION OF PRRT |
![]() |
Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis |
![]() |
Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome. |
![]() |
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. |
![]() |
Transient diabetes insipidus in pregnancy |
![]() |
Transsphenoidal pituitary surgery in the elderly is safe and effective. |
![]() |
Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment |
![]() |
TRANSSPHENOIDAL SURGERY FOR PITUITARY TUMOURS: FREQUENCY AND PREDICTORS OF DELAYED HYPONATRAEMIA AND THEIR RELATIONSHIP TO EARLY READMISSION. |
![]() |
Treating prolactinomas with dopamine agonists: always worth the gamble? |
![]() |
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement |
![]() |
Treatment of advanced neuroendocrine tumours with the radiolabelled somatostatin analogue octreotide |
![]() |
Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG]. |
![]() |
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. |
![]() |
Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors |
![]() |
Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement. |
![]() |
Understanding the treatment algorithm of patients with metastatic pancreatic neuroendocrine neoplasms: A single-institution retrospective analysis comparing outcomes of chemotherapy, molecular targeted therapy and peptide receptor radionuclide thera |
![]() |
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients |
![]() |
Unmet needs in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3) |
![]() |
Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease. |
![]() |
The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. |
![]() |
A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children |
![]() |
Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice |
![]() |
Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors |
![]() |
What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1? |
![]() |
When imaging fails: pre-operative localization and treatment of a ganglioneuroma |
![]() |
Whole-exome sequencing studies of nonfunctioning pituitary adenomas |
![]() |
The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis. |
![]() |
Work-up and management of paediatric Cushing's syndrome. |
![]() ![]() |
সম্পাদকীয় |
![]() |